Topical Omidenepag Isopropyl Lowers Intraocular Pressure in Normal and Glaucomatous Cats: A Pilot Study
Veterinary Ophthalmology · 2025
DOI: 10.1111/vop.70125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2025. Verfasst von Kazuya Oikawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Intraocular Pressure, Cat Diseases, Glaucoma, Pyridines. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, Research to Prevent Blindness, NIH HHS.
Abstract (Originalsprache)
Purpose
To evaluate the effects of topical prostaglandin E2 receptor 2 (EP2) agonist, omidenepag isopropyl (OMDI), on intraocular pressure (IOP) and pupil diameter (PD) in normal cats and cats with feline congenital glaucoma (FCG). Animals Studied Ten FCG cats and 8 normal cats.
Methods
In this prospective, randomized, placebo‐controlled, masked pilot study, normal and FCG cats received one drop of 0.002% OMDI ophthalmic solution in one eye and artificial tears in the contralateral eye. IOP and PD were measured by a masked observer at baseline and at multiple time points up to 32–36 h post‐administration.
Results
Topical 0.002% OMDI significantly lowered IOP compared to controls in both normal and FCG cats. In normal cats, the effect was significant up to 12 h after instillation, with a maximal reduction from baseline of 7.3 mmHg (43.5%). In FCG cats, the effect was significant from 2 to 8 h after instillation, with a maximal reduction from baseline of 16.7 mmHg (60.2%). No significant effect on pupil diameter or signs of ocular irritation was observed in either group.
Conclusions
A single topical drop of 0.002% OMDI significantly lowers IOP in normal and FCG cats without inducing miosis. Our findings support that topical selective EP2 agonists may be a promising therapeutic option for feline glaucoma and provide information relevant to dosing intervals for future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Surgical Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- McPherson Eye Research Institute, Madison, Wisconsin, USA.
ORCID-Profile: Kazuya Oikawa, Julie A Kiland, Gillian J McLellan
Förderung
- NEI NIH HHS
- Research to Prevent Blindness
- NIH HHS
- ACVO Vision for Animals Foundation
- American College of Veterinary Ophthalmologists Vision for Animals Foundation
- National Institutes of Health
Zitieren
APA
Oikawa, K., Kiland, J. A., Zaluckyj, H. G., Rai, A., Mathu, V., & McLellan, G. J. (2025). Topical Omidenepag Isopropyl Lowers Intraocular Pressure in Normal and Glaucomatous Cats: A Pilot Study. Veterinary Ophthalmology. https://doi.org/10.1111/vop.70125
Vancouver
Oikawa K, Kiland JA, Zaluckyj HG, Rai A, Mathu V, McLellan GJ. Topical Omidenepag Isopropyl Lowers Intraocular Pressure in Normal and Glaucomatous Cats: A Pilot Study. Veterinary Ophthalmology. 2025. doi:10.1111/vop.70125
BibTeX
@article{Oikawa2025,
author = {Oikawa, Kazuya and Kiland, Julie A and Zaluckyj, Hayden G and Rai, Anjali and Mathu, Virginia and McLellan, Gillian J},
title = {Topical Omidenepag Isopropyl Lowers Intraocular Pressure in Normal and Glaucomatous Cats: A Pilot Study},
journal = {Veterinary Ophthalmology},
year = {2025},
doi = {10.1111/vop.70125}
}
EUVIMED